Engineering pH-Sensitive Stable Nanovesicles for Delivery of MicroRNA Therapeutics

MicroRNAs (miRNAs) are small non-coding endogenous RNAs, which are attracting a growing interest as therapeutic molecules due to their central role in major diseases. However, the transformation of these biomolecules into drugs is limited due to their unstability in the bloodstream, caused by nuclea...

ver descrição completa

Detalhes bibliográficos
Autores: Boloix, Ariadna, Feiner Gracia, Natalia, Kober, Marina, Repetto, Javier, Pascarella, Rosa, Soriano, Aroa, Masanas, Marc, Segovia, Nathaly, Vargas Nadal, Guillem, Merlo Mas, Josep, Danino, Dganit, Abutbul-Ionita, Inbal, Foradada, Laia, Roma, Josep, Cordoba, Alba, Sala, Santi, Sánchez de Toledo, Josep, Gallego Melcón, Soledad, Veciana, Jaume, Albertazzi, Lorenzo, Segura, Miguel F., Ventosa, Nora
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2022
País:España
Recursos:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/185015
Acesso em linha:https://hdl.handle.net/2445/185015
Access Level:acceso abierto
Palavra-chave:Tumors
Micro RNAs
MicroRNAs
id ES_ad5f42e0cd85aff1a52bd7098078a563
oai_identifier_str oai:recercat.cat:2445/185015
network_acronym_str ES
network_name_str España
repository_id_str
spelling Engineering pH-Sensitive Stable Nanovesicles for Delivery of MicroRNA TherapeuticsBoloix, AriadnaFeiner Gracia, NataliaKober, MarinaRepetto, JavierPascarella, RosaSoriano, AroaMasanas, MarcSegovia, NathalyVargas Nadal, GuillemMerlo Mas, JosepDanino, DganitAbutbul-Ionita, InbalForadada, LaiaRoma, JosepCordoba, AlbaSala, SantiSánchez de Toledo, JosepGallego Melcón, SoledadVeciana, JaumeAlbertazzi, LorenzoSegura, Miguel F.Ventosa, NoraTumorsMicro RNAsMicroRNAsTumorsMicroRNAs (miRNAs) are small non-coding endogenous RNAs, which are attracting a growing interest as therapeutic molecules due to their central role in major diseases. However, the transformation of these biomolecules into drugs is limited due to their unstability in the bloodstream, caused by nucleases abundantly present in the blood, and poor capacity to enter cells. The conjugation of miRNAs to nanoparticles (NPs) could be an effective strategy for their clinical delivery. Herein, the engineering of non-liposomal lipid nanovesicles, named quatsomes (QS), for the delivery of miRNAs and other small RNAs into the cytosol of tumor cells, triggering a tumor-suppressive response is reported. The engineered pH-sensitive nanovesicles have controlled structure (unilamellar), size (<150 nm) and composition. These nanovesicles are colloidal stable (>24 weeks), and are prepared by a green, GMP compliant, and scalable one-step procedure, which are all unavoidable requirements for the arrival to the clinical practice of NP based miRNA therapeutics. Furthermore, QS protect miRNAs from RNAses and when injected intravenously, deliver them into liver, lung, and neuroblastoma xenografts tumors. These stable nanovesicles with tunable pH sensitiveness constitute an attractive platform for the efficient delivery of miRNAs and other small RNAs with therapeutic activity and their exploitation in the clinics.Wiley2022202220222022info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion14 p.application/pdfapplication/pdfhttps://hdl.handle.net/2445/185015Articles publicats en revistes (Institut de Bioenginyeria de Catalunya (IBEC))reponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)InglésReproducció del document publicat a: https://doi.org/10.1002/smll.202101959Small, 2022, vol. 18https://doi.org/10.1002/smll.202101959cc by (c) Boloix, Ariadna et al, 2022http://creativecommons.org/licenses/by/3.0/es/info:eu-repo/semantics/openAccessoai:recercat.cat:2445/1850152026-05-29T05:05:01Z
dc.title.none.fl_str_mv Engineering pH-Sensitive Stable Nanovesicles for Delivery of MicroRNA Therapeutics
title Engineering pH-Sensitive Stable Nanovesicles for Delivery of MicroRNA Therapeutics
spellingShingle Engineering pH-Sensitive Stable Nanovesicles for Delivery of MicroRNA Therapeutics
Boloix, Ariadna
Tumors
Micro RNAs
MicroRNAs
Tumors
title_short Engineering pH-Sensitive Stable Nanovesicles for Delivery of MicroRNA Therapeutics
title_full Engineering pH-Sensitive Stable Nanovesicles for Delivery of MicroRNA Therapeutics
title_fullStr Engineering pH-Sensitive Stable Nanovesicles for Delivery of MicroRNA Therapeutics
title_full_unstemmed Engineering pH-Sensitive Stable Nanovesicles for Delivery of MicroRNA Therapeutics
title_sort Engineering pH-Sensitive Stable Nanovesicles for Delivery of MicroRNA Therapeutics
dc.creator.none.fl_str_mv Boloix, Ariadna
Feiner Gracia, Natalia
Kober, Marina
Repetto, Javier
Pascarella, Rosa
Soriano, Aroa
Masanas, Marc
Segovia, Nathaly
Vargas Nadal, Guillem
Merlo Mas, Josep
Danino, Dganit
Abutbul-Ionita, Inbal
Foradada, Laia
Roma, Josep
Cordoba, Alba
Sala, Santi
Sánchez de Toledo, Josep
Gallego Melcón, Soledad
Veciana, Jaume
Albertazzi, Lorenzo
Segura, Miguel F.
Ventosa, Nora
author Boloix, Ariadna
author_facet Boloix, Ariadna
Feiner Gracia, Natalia
Kober, Marina
Repetto, Javier
Pascarella, Rosa
Soriano, Aroa
Masanas, Marc
Segovia, Nathaly
Vargas Nadal, Guillem
Merlo Mas, Josep
Danino, Dganit
Abutbul-Ionita, Inbal
Foradada, Laia
Roma, Josep
Cordoba, Alba
Sala, Santi
Sánchez de Toledo, Josep
Gallego Melcón, Soledad
Veciana, Jaume
Albertazzi, Lorenzo
Segura, Miguel F.
Ventosa, Nora
author_role author
author2 Feiner Gracia, Natalia
Kober, Marina
Repetto, Javier
Pascarella, Rosa
Soriano, Aroa
Masanas, Marc
Segovia, Nathaly
Vargas Nadal, Guillem
Merlo Mas, Josep
Danino, Dganit
Abutbul-Ionita, Inbal
Foradada, Laia
Roma, Josep
Cordoba, Alba
Sala, Santi
Sánchez de Toledo, Josep
Gallego Melcón, Soledad
Veciana, Jaume
Albertazzi, Lorenzo
Segura, Miguel F.
Ventosa, Nora
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Tumors
Micro RNAs
MicroRNAs
Tumors
topic Tumors
Micro RNAs
MicroRNAs
Tumors
description MicroRNAs (miRNAs) are small non-coding endogenous RNAs, which are attracting a growing interest as therapeutic molecules due to their central role in major diseases. However, the transformation of these biomolecules into drugs is limited due to their unstability in the bloodstream, caused by nucleases abundantly present in the blood, and poor capacity to enter cells. The conjugation of miRNAs to nanoparticles (NPs) could be an effective strategy for their clinical delivery. Herein, the engineering of non-liposomal lipid nanovesicles, named quatsomes (QS), for the delivery of miRNAs and other small RNAs into the cytosol of tumor cells, triggering a tumor-suppressive response is reported. The engineered pH-sensitive nanovesicles have controlled structure (unilamellar), size (<150 nm) and composition. These nanovesicles are colloidal stable (>24 weeks), and are prepared by a green, GMP compliant, and scalable one-step procedure, which are all unavoidable requirements for the arrival to the clinical practice of NP based miRNA therapeutics. Furthermore, QS protect miRNAs from RNAses and when injected intravenously, deliver them into liver, lung, and neuroblastoma xenografts tumors. These stable nanovesicles with tunable pH sensitiveness constitute an attractive platform for the efficient delivery of miRNAs and other small RNAs with therapeutic activity and their exploitation in the clinics.
publishDate 2022
dc.date.none.fl_str_mv 2022
2022
2022
2022
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/185015
url https://hdl.handle.net/2445/185015
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Reproducció del document publicat a: https://doi.org/10.1002/smll.202101959
Small, 2022, vol. 18
https://doi.org/10.1002/smll.202101959
dc.rights.none.fl_str_mv cc by (c) Boloix, Ariadna et al, 2022
http://creativecommons.org/licenses/by/3.0/es/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv cc by (c) Boloix, Ariadna et al, 2022
http://creativecommons.org/licenses/by/3.0/es/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 14 p.
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Wiley
publisher.none.fl_str_mv Wiley
dc.source.none.fl_str_mv Articles publicats en revistes (Institut de Bioenginyeria de Catalunya (IBEC))
reponame:Recercat. Dipósit de la Recerca de Catalunya
instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
instname_str Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
reponame_str Recercat. Dipósit de la Recerca de Catalunya
collection Recercat. Dipósit de la Recerca de Catalunya
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869416433929158656
score 15,812429